CompletedPhase 3NCT00085709

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

Studying Acute basophilic leukemia

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: SWOG Cancer Research Network
Principal Investigator: Stephen H. Petersdorf, MD
Seattle Cancer Care Alliance
Intervention: gemtuzumab ozogamicin(drug)
Enrollment: 637 enrolled
Eligibility: 18-60 years · All sexes
Timeline: 2004 – 2014

Study locations (30)

Providence Cancer Center, Anchorage, Alaska, United States
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Alta Bates Summit Comprehensive Cancer Center, Berkeley, California, United States
Peninsula Medical Center, Burlingame, California, United States
Marin Cancer Institute at Marin General Hospital, Greenbrae, California, United States
Sutter Health - Western Division Cancer Research Group, Greenbrae, California, United States
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
California Pacific Medical Center - California Campus, San Francisco, California, United States
Sutter Solano Medical Center, Vallejo, California, United States
Center for Cancer Care and Research at Watson Clinic, LLP, Lakeland, Florida, United States
Phoebe Cancer Center at Phoebe Putney Memorial Hospital, Albany, Georgia, United States
Medical Center of Central Georgia, Macon, Georgia, United States
Saint Anthony's Hospital at Saint Anthony's Health Center, Alton, Illinois, United States
St. Joseph Medical Center, Bloomington, Illinois, United States
+15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00085709 on ClinicalTrials.gov

Other trials for Acute basophilic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute basophilic leukemia →

← Back to all trials